(-)-β-Pinene

CAS No. 18172-67-3

(-)-β-Pinene( Nopinene )

Catalog No. M21573 CAS No. 18172-67-3

(-)-β-Pinene is inhibit infectious bronchitis virus (IBV) with an IC50 of 1.32 mMwith antimicrobial activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 30 In Stock
5MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (-)-β-Pinene
  • Note
    Research use only, not for human use.
  • Brief Description
    (-)-β-Pinene is inhibit infectious bronchitis virus (IBV) with an IC50 of 1.32 mMwith antimicrobial activity.
  • Description
    (-)-β-Pinene is inhibit infectious bronchitis virus (IBV) with an IC50 of 1.32 mMwith antimicrobial activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Nopinene
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Bacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    18172-67-3
  • Formula Weight
    136.23
  • Molecular Formula
    C10H16
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (734.05 mM)
  • SMILES
    CC1(C)[C@@H]2C[C@H]1C(=C)CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yang Z et al. Comparative anti-infectious bronchitis virus (IBV) activity of (-)-pinene: effect on nucleocapsid (N) protein. Molecules. 2011 Jan 25;16(2):1044-54.
molnova catalog
related products
  • Inh2-B1

    Inh2-B1 (STK1 inhibitor B1) is a novel specific S aureus Ser/Thr protein kinase (STK1) inhibitor with IC50 of 49 uM.

  • JCP251

    JCP251 is a selective small molecule inhibitor of S. aureus serine hydrolase FphB, effectively reduces infectivity in vivo.

  • Capreomycin sulfate

    A peptide antibiotic, commonly grouped with the aminoglycosides, which is given in combination with other antibiotics for MDR-tuberculosis.